Terms: = Leukemia AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
582 results:
1. A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.
Sekiguchi Y; Tsutsumi H; Gomyo A; Kudo M; Maseki N; Iizaki Y; Kawamura M; Kobayashi K; Nitta H; Noguchi M; Wakita S; Yamaguchi H; Kobayashi H
Gan To Kagaku Ryoho; 2024 Mar; 51(3):291-297. PubMed ID: 38494811
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a novel fusion gene, rara::ANKRD34C, in acute promyelocytic leukemia.
Chen Y; Pan M; Chen L; Peng M; Liu Z; Fang Y; Du Y; Yang Y; Xu P
Ann Hematol; 2024 Apr; 103(4):1181-1185. PubMed ID: 38294534
[TBL] [Abstract] [Full Text] [Related]
3. [Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].
Jiao Y; Jiang YH; Liu B; Mi RH; Bi LJ; Xu QX
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):86-95. PubMed ID: 38246784
[No Abstract] [Full Text] [Related]
4. Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::rara fusion.
Xu J; Li H; Wang Z; Wang M; Li Q; Hang X; Xu J; Ji J; Chen C; Liu Y; Niu T
Mol Carcinog; 2024 Apr; 63(4):553-557. PubMed ID: 38131515
[TBL] [Abstract] [Full Text] [Related]
5. The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
Erkner E; Hentrich T; Schairer R; Fitzel R; Secker-Grob KA; Jeong J; Keppeler H; Korkmaz F; Schulze-Hentrich JM; Lengerke C; Schneidawind D; Schneidawind C
Oncogene; 2024 Jan; 43(4):281-293. PubMed ID: 38030791
[TBL] [Abstract] [Full Text] [Related]
6. Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid leukemia Using Flow Cytometry.
Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
[TBL] [Abstract] [Full Text] [Related]
7. Acute promyelocytic leukemia masquerading as myeloid maturation arrest- A Case report.
Kannan N; Dass J; Viswanathan G; Khokhar P; Aggarwal M
J Clin Exp Hematop; 2023; 63(3):193-196. PubMed ID: 37766564
[TBL] [Abstract] [Full Text] [Related]
8. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia.
Li H; Hou J; Fu Y; Zhao Y; Liu J; Guo D; Lei R; Wu Y; Tang L; Fan S
Ann Hematol; 2023 Dec; 102(12):3357-3367. PubMed ID: 37726492
[TBL] [Abstract] [Full Text] [Related]
9. Cytogenetically Cryptic Acute Promyelocytic leukemia: A Diagnostic Challenge.
Mohebnasab M; Li P; Hong B; Dunlap J; Traer E; Fan G; Press RD; Moore SR; Xie W
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685882
[TBL] [Abstract] [Full Text] [Related]
10. Use of tamibarotene, a potent and selective rarα agonist, in combination with azacitidine in patients with relapsed and refractory AML with
Stein EM; de Botton S; Cluzeau T; Pigneux A; Liesveld JL; Cook RJ; Rousselot P; Rizzieri DA; Braun T; Roboz GJ; Lebon D; Heiblig M; Baker K; Volkert A; Paul S; Rajagopal N; Roth DA; Kelly M; Peterlin P
Leuk Lymphoma; 2023 Dec; 64(12):1992-2001. PubMed ID: 37571998
[TBL] [Abstract] [Full Text] [Related]
11. Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties.
Xiao P; Duan Z; Liu Z; Chen L; Zhang D; Liu L; Zhou C; Gan J; Dong Z; Yang CG
J Med Chem; 2023 Jul; 66(14):9731-9752. PubMed ID: 37418628
[TBL] [Abstract] [Full Text] [Related]
12. [Research Progress of m6A Demethylase FTO and Its Inhibitors in Acute Myeloid leukemia --Review].
Fang ZH; Zheng SY; Feng WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):902-906. PubMed ID: 37356958
[TBL] [Abstract] [Full Text] [Related]
13. The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer.
Adinew GM; Messeha S; Taka E; Ahmed SA; Soliman KFA
Cancer Genomics Proteomics; 2023; 20(3):247-272. PubMed ID: 37093683
[TBL] [Abstract] [Full Text] [Related]
14. Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.
Vundinti BR; Korgaonkar S; Dhangar S; Jijina F; Shanmukhaiah C
J Cancer Res Ther; 2023; 19(2):340-346. PubMed ID: 37006070
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study.
Scott S; Dillon R; Thiede C; Sadiq S; Cartwright A; Clouston HJ; Travis D; Mokretar K; Potter N; Chantry A; Whitby L
Blood Adv; 2023 Jul; 7(14):3686-3694. PubMed ID: 36939402
[TBL] [Abstract] [Full Text] [Related]
16. The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-rara.
Jaffray EG; Tatham MH; Mojsa B; Liczmanska M; Rojas-Fernandez A; Yin Y; Ball G; Hay RT
J Cell Biol; 2023 Apr; 222(4):. PubMed ID: 36880596
[TBL] [Abstract] [Full Text] [Related]
17. treatment Outcomes Of Patients With Newly Diagnosed Acute Promyelocytic leukemia; Experience From A Developing Country.
Javed H; Chudary QU; Iftikhar R; Shahbaz N; Ali M; Hamayun S
J Ayub Med Coll Abbottabad; 2022; 34(4):791-796. PubMed ID: 36566401
[TBL] [Abstract] [Full Text] [Related]
18. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
[TBL] [Abstract] [Full Text] [Related]
19. Targeting rara overexpression with tamibarotene, a potent and selective rarα agonist, is a novel approach in AML.
de Botton S; Cluzeau T; Vigil C; Cook RJ; Rousselot P; Rizzieri DA; Liesveld JL; Fenaux P; Braun T; Banos A; Jurcic JG; Sekeres MA; Savona MR; Roboz GJ; Bixby D; Madigan K; Volkert A; Stephens K; Kang-Fortner Q; Baker K; Paul S; McKeown M; Carulli J; Eaton M; Hodgson G; Fiore C; Kelly MJ; Roth DA; Stein EM
Blood Adv; 2023 May; 7(9):1858-1870. PubMed ID: 36477975
[TBL] [Abstract] [Full Text] [Related]
20. Derivative 6 as an additional chromosomal abnormality along with t(15;17): A case report.
Dalvi RC; Mandava S; Pais AP; Kokate PP; Sinha N; Nath UK
Indian J Cancer; 2022; 59(3):419-421. PubMed ID: 36412315
[TBL] [Abstract] [Full Text] [Related]
[Next]
